CASSAVA SCIENCES INC financial data

Symbol
SAVA on Nasdaq
Location
Austin, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 399 % +17.7%
Debt-to-equity 27.26 %
Return On Assets -75.26 % -7.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48,307,896 shares +0.41%
Common Stock, Shares, Outstanding 48,307,896 shares +0.69%
Entity Public Float 558,000,000 USD -42.3%
Common Stock, Value, Issued 48,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 48,308,000 shares +0.69%
Weighted Average Number of Shares Outstanding, Diluted 48,308,000 shares +0.69%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 43,267,000 USD -36.2%
General and Administrative Expense 68,058,000 USD +1.7%
Operating Income (Loss) -111,325,000 USD +17.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -106,031,000 USD -5%
Earnings Per Share, Basic -2 USD/shares -5.2%
Earnings Per Share, Diluted -2 USD/shares -59.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 106,080,000 USD -28.8%
Other Assets, Current 106,000 USD -44.8%
Assets, Current 108,910,000 USD -46.2%
Property, Plant and Equipment, Net 20,823,000 USD -1.5%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 37,000 USD -79%
Assets 129,733,000 USD -42%
Accounts Payable, Current 10,338,000 USD +1.2%
Employee-related Liabilities, Current 362,000 USD -81.4%
Accrued Liabilities, Current 7,044,000 USD +1.1%
Liabilities, Current 48,046,000 USD -15.8%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 119,000 USD +48.8%
Liabilities 48,165,000 USD -15.7%
Retained Earnings (Accumulated Deficit) -483,545,000 USD -28.1%
Stockholders' Equity Attributable to Parent 81,568,000 USD -51.1%
Liabilities and Equity 129,733,000 USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11,336,000 USD +40.7%
Net Cash Provided by (Used in) Financing Activities 90,000 USD -99.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 120,000,000 shares 0%
Common Stock, Shares, Issued 48,307,896 shares +0.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 188,978,000 USD +32.8%
Deferred Tax Assets, Valuation Allowance 96,689,000 USD +25%
Deferred Tax Assets, Gross 96,689,000 USD +25%
Depreciation 761,000 USD -29.4%
Payments to Acquire Property, Plant, and Equipment 0 USD
Property, Plant and Equipment, Gross 24,730,000 USD +2.4%
Operating Lease, Liability, Current 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 43,148,000 USD +29.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits 9,242,000 USD +9.9%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 565,065,000 USD +3.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 180,000 USD -59.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 19,952,000 USD +57.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%